Tag: ESC 2025
No benefit seen when using biomarker-based risk scores to personalise AF...
An individually tailored, multidimensional risk-based treatment strategy was not associated with improvements in clinical outcomes compared with usual guideline-based care in patients with atrial...
Boston Scientific announces late-breaking data on Farapulse and Watchman FLX technologies...
At the 2025 European Society of Cardiology (ESC) congress (29 August–1 September, Madrid, Spain), Boston Scientific shared two late-breaking presentations pertaining to its Farapulse...
Study finds comparable outcomes between reconditioned and new pacemakers
Procedure-related infection rates are similar between reconditioned and new pacemakers, potentially offering a "new hope" to patients in low- and middle-income countries (LMICs), according...
Digital twin technology helps reduce atrial arrhythmia recurrence after catheter ablation...
Adding digital twin-guided ablation to a standard ablation technique can improve outcomes in patients with persistent atrial fibrillation (AF), according to late-breaking research presented...
Procedural success with PFA “not superior” to radiofrequency ablation in paroxysmal...
Pulsed field ablation (PFA) did not demonstrate superior efficacy to radiofrequency (RF) ablation in patients with drug-resistant, paroxysmal atrial fibrillation (AF) within the BEAT-PAROX-AF...
Multiple datasets suggest positive safety and performance with OmniaSecure defibrillation lead
Researchers recently presented three new datasets reinforcing the safety and performance of Medtronic’s OmniaSecure defibrillation lead at the 2025 European Society of Cardiology (ESC)...
ICDs fail to reduce mortality in selected heart attack patients with...
Prophylactic implantable cardioverter defibrillator (ICD) therapy does not appear to reduce mortality in patients with a prior myocardial infarction (MI), persistent moderate left ventricular...
J&J unveils real-world results from VARIPURE substudy at ESC 2025
Johnson & Johnson (J&J) MedTech has today announced acute safety and effectiveness results from the VARIPURE substudy of the SECURE study evaluating the company’s Varipulse...
Remote AF screening using an ECG patch demonstrates modest benefits
A mail-based atrial fibrillation (AF) screening programme with electrocardiogram (ECG) patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure...
New data indicate lifelong anticoagulation “might not be necessary” in all...
Discontinuing oral anticoagulation (OAC) therapy may result in a lower risk of a composite of stroke, systemic embolism or major bleeding versus continuing OAC...
Increasing potassium levels improves outcomes in patients at high risk of...
Targeting high-normal potassium levels can reduce the risk of arrhythmias, hospitalisation for heart failure or arrhythmia, and death, compared with no intervention, according to...